SS
GRI

SBI Securities’s GRI Bio GRI Stock Holding History

SBI Securities’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed -$9 – 4129
2026
Q1 		$9 Hold
4
– – ﹤0.01% 3855
2025
Q4 		$29 Hold
4
– – ﹤0.01% 3702
2025
Q3 		$241 Hold
4
– – ﹤0.01% 3255
2025
Q2 		$151 Hold
4
– – ﹤0.01% 3401
2025
Q1 		$374 Hold
4
– – ﹤0.01% 2982
2024
Q4 		$1.66K Buy
+4
New +$1.37K ﹤0.01% 2378

Other funds holding GRI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

SBI Securities's GRI Position: Q2 2026 in Review

SBI Securities sold out of GRI Bio (GRI) in Q2 2026, closing a stake of 4 shares — an estimated $9 sold.

SBI Securities first reported a position in GRI in Q4 2024 and held it in 6 quarters. The position peaked at $1.66K in Q4 2024. 8 funds tracked by Wall St. Rank hold GRI as of Q2 2026.

  • SBI Securities reported no remaining GRI Bio position as of Q2 2026 after selling out during the quarter.
  • SBI Securities sold 4 GRI Bio shares in Q2 2026, an estimated $9.
  • SBI Securities first reported a position in GRI Bio in Q4 2024 and held it in 6 quarters.
  • SBI Securities's GRI Bio position peaked at $1.66K in Q4 2024.
  • 8 funds tracked by Wall St. Rank held GRI Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.